Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
KRAS G12C-mutated Non-Small Cell Lung Cancer and advanced Colorectal Cancer.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.